Tevimbra is under clinical development by BeiGene and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase II drugs for Metastatic Colorectal Cancer have a 34% phase ...

Vactosertib is under clinical development by MedPacto and currently in Phase I for Metastatic Colorectal Cancer.

23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting ... Unlocking the Secrets of Cancer Metastasis: Study Provides New Insights ...

The FDA has approved subcutaneous nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) to treat a range of solid tumor malignancies.

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

Linda Chavez, 34, was diagnosed with terminal lung cancer after years of ignoring symptoms like a persistent cough, bone pain ...

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

Shares of Purple Biotech Ltd (NASDAQ:PPBT – Get Free Report) traded down 2.1% on Thursday . The company traded as low as $4.28 and last traded at $4.59. 140,696 shares changed hands during trading, a ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. In a new survey, 40% of adults over 50 said an age ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.